95% CI, 3.3 to 7.7 lb [1.5 to 3.5 kg]) greater than placebo for the 120-mg and 60-mg doses, respectively
Blood Sugar Changes People using insulin or medications that stimulate insulin release may have a greater risk of hypoglycemia when a GLP-1-based medication is added
In summary, tesofensine shows promise as a potential treatment option for eating disorders due to its ability to modulate appetite and eating behaviors
Semaglutide, a medication designed to support weight loss, works by helping control appetite and regulating blood sugar, which over time can lead to gradual, steady weight loss
However, the severity and occurrence of these side effects can differ
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation